Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Latest News

Market capUnder $500B
All Over $50MOver $300MOver $2BOver $10B
All Under $1BUnder $10BUnder $100BUnder $500B
SectorsAll
Filter by sector
Monday, October 19, 2026· 9307 stock ideas· 219 writers·
19,486 views· 9,002 clicks

The Agentic AI Roadmap for SaaS

SaaS companies including Salesforce, ServiceNow, CrowdStrike, Synopsys and Veeva are ranked by agentic AI progress, from pilots to monetization and new usage-based business models.

CRM $197BCRWD $233B
Jimmy's Journal 1 click

From X

@aleabitoreddit

Serenity on X

Feels like the public interpretation is all wrong… I’m pretty sure $MSFT backing out on NScale deal is bullish for Neoclouds like $NBIS or even $IREN with energized capacity with Microsoft? Pretend Microsoft just ate a bunch of Chipotle burittos: - They order toilet paper delivery scheduled Q1 2027 - NScale says: sorry 3-4+ year delay of the toilet paper (into 2030’s) because of UK grid constraints - Microsoft still urgently needs toilet paper so they will get it elsewhere The cancellation does send warnings about what happens if a Neocloud can’t execute on contracted demand. But that just makes the other toilet paper sellers more valuable since Microsoft will go elsewhere for supply.
@aleabitoreddit

Serenity on X

I don't think it's unclear, but I do think segments outside of photonics are noise for what drives valuations (which I don't think management understood). Next earnings, $SIVE should use laser capacity revenue ceiling from foundry allocations + existing fabs as the core metric alongside customer qualification diversity. Not defending what the definition of a revenue pipeline is and using current term cellular AllSpace contract revenue as an example. Potential volume from $GFS probably dwarfs revenue from other segments. Talking about existing qualification cycles is enough since investors how they convert given 1.6T/NPO/CPO transitions are coming up.
@aleabitoreddit 1 click

Serenity on X

Last major $SIVE disclosure was 100M CW DFB laser capacity Q4 2027. And a new foundry partner (that makes 2 including Win Semi). Expected $JBL revenue coming in H1 2027 (with lasers for Jabil's 1.6T LRO scaling up H2 2027). There's channel checks along the way like CIOE where Sivers was engaged with Chinese pluggable makers + laser ASPs being raised. 70mW/100mW ranges were the most tight to Chinese pluggable makers, which was surprising. Biggest industry read through was $LITE selling out into 2029, making agreements for 2030, and having hyperscalers pay for capacity expansion for 2031. I don't think anyone has enough information to do any sort of accurate modeling for $SIVE like you can for $AAOI given they don't release product breakdown + capacity targets by quarter. The 200mW NPO lasers Sivers is sampling is likely different ASP than your 70mW lasers shipped to pluggable makers. And your custom CPO lasers are different pricing too. Like all sampling/qualification players from $AEHR to $AAOI back in 2025, usually the risk/reward comes in whether qualifications convert and what new customers they have, which is always a risk. In a bull case, if $SIVE comes online with 300m laser supply (2:1 implied ratio, already has "tremendous" supply online from likely US fab) during a structural shortage. Pluggable players like $JBL, 6 other vendors. $GFS as the reference design laser for their CPO/NPO platform. Your minor players vendors like $POET, $AEVA and other players end up scaling. And all the other custom products they hinted they were working on in the past for CPO years back. I think the probability that they cook is higher since there's so many ongoing qualifications during a bottleneck. We've already seen ownership changes from Swedish investors to US/International retail from $SIVE shareholder disclosures. My guess is that trends institutional from retail before US listing next year amid the market correction. Think people forgot institutions have already financed their expansion, which was a 700M SEK round 100%+ ago (multiple times oversubscribed). And that $SIVE uses primarily external fabs, so it's not the same as a lot of the major financing concerns affecting Neoclouds. Anyway, up to management execution, I'm not running Sivers so no clue what other companies are working with them now, whether it's Cambridge or some other US player like Semtec. TLDR: - Just need to wait for earnings for more disclosures around qualifications + partners, only so much public can guess from channel checks and supplier mapping. Not quite the same as $LITE CEO where you can see the guy on Fox news or Bloomberg interviews every week (which is a good thing)
@aleabitoreddit 2 clicks

Serenity on X

Last time I've seen "It's all over" type posts was... 3 months ago during the situational awareness liquidation. And... 3 months ago before that... with Iran tensions + Oil + Helium + LNG fears/pricing. And... few months ago before that. I'm sure everyone remembers Deepseek back in like 2025 Each one had genuine risks, with rate hikes/margin liquidations to oil prices + supply disruption. And now financing/credit markets. Not trying to downplay the risks but haven't seen it materialize in the companies I'm tracking (eg. optical sector) given counterparty types + sector visibility + architectural shifts in 2027-2028. For example in this $LITE CEO interview, the guy said there hasn't been any order cancellation/delays given rate hikes. But obviously neocloud sector that uses heavy debt leverage might be different. I've seen that the general sentiment was a recovery after midterms in 2 weeks, I'm not the type to give predictions like that. We'll see Directionally bullish on certain sectors of AI supply chain like memory/photonics, but everything was sold off indiscriminately, even if they're not exactly the same trade.
@aleabitoreddit

Serenity on X

I can't give advice on what others should do but from what I'm seeing from $AAOI revenue ramp, it looks something like this from disclosed capacity. -> $858M Q1 2027 -> $1.29B Q2 2027 -> $1.62B Q3 2027 -> $1.89B Q4 2027 -> $2.14B Q1 2028 They're sitting on $6.8B MC right now. I'd be very impressed if they do $7.5B exit annualized revenue run rate in 2027 off 40% gross margins and markets assigned them the same valuation. And judging from $LITE making capacity agreements into 2030-2031... I don't quite think demand stalls out after 2027-2028. Anyway, lot of execution risk obviously, but H1 2027 inflection point is pretty close, so I'm personally waiting.
@aleabitoreddit

Serenity on X

$LITE CEO interview on demand, counterparty + financing risk: - "CFO of $GOOGL came on and reported capex going up Y/Y, we expect hyperscalers for report an increase in capex in earnings. Based on what we see, we see their spend going up." - "The purchase agreements we have, to a large degree, are noncancellable." - The difference between Lumentum and companies like $AVGO, "we are not as dependent on AI datacenter buildout going forward" There's a conversion between electrical products to optical products" creating structural demand. Q: When do you see able to see yourself having more inventory? (catching up to surge in demand) - When we look at demand, there is "no end in sight" TLDR: Financing risk and demand aren't equally distributed across AI supply chains. But markets are just selling everything off together. As for photonics in specific, I said this before, but increasing optical content per XPU + CPO/NPO adoption keeps going up so we'll likely see sector spend go up, even if aggregate capex goes down. There's the usual "no end to demand in sight" commentary, but $LITE does have capacity commitments into 2029 now... and are negotiating for 2030. (with new information that most of which are likely hyperscalers + non-cancellable) So doesn't quite sound like it's all over for the AI trade, especially photonics.

Investor Letters

All letters

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

Semtech Analyst Day Review

Semtech raised Q3 guidance and targets $3.2 billion of fiscal 2030 revenue, excluding upside from its AI data-center optical and copper…

SMTC $16B
CV's Substack 11 clicks
NXPI · long

Nxp Semiconductors NV

NXP Semiconductors, the global automotive-chip leader, has delivered 12.5% compounded EPS growth and is presented as a long investment.

NXPI $57B
Value Investors Club 1 click

ALTO- ALTO ingredients

ALTO Ingredients trades near half of book value after plant upgrades and lower corn prices set up a recovery in crush margins and cash flow.

ALTO $292M
Sylence Capital 1 click

Notes and Updates

ECIP recipient banks could repurchase Treasury preferred shares at steep discounts, potentially lifting book value, while Hawaiian Electric…

HE $1.5BUBAB $183M
Exploring with Alluvial Capital

Mereo Biopharma

Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.

MREO $49M
Raging Bull Investments

Revisiting An Old Idea

Instil Bio leased its 128,000-square-foot Tarzana life-sciences building to AstraZeneca for 15 years at $7.52 million annual rent,…

TIL $40M
Raging Bull Investments

Have a source we’re missing? Send your pick

Recent recaps

Latest recap

Sunday, October 18 32 stock ideas
  • What Lies Beneath: The Developer Building a Data Center on a Former Army Dump Laced With Munitions and Carcinogens Hunterbrook
  • DigitalOcean CEO: ‘We are not going to be extraordinarily leveraged like some others’ The Technology Letter
Read the recap

All recaps

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 108

YouTube 4

Blogs 17

Seeking Alpha 52 of 239

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

89 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.

Anything we’re missing?

Send us a pick